Malignant hyperthermia: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: {{subpages}} '''Malignant hyperthermia''' is "rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia."<ref>{{MeSH}}</ref> ==References== <re...) |
mNo edit summary |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
'''Malignant hyperthermia''' is "rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia."<ref>{{MeSH}}</ref> | '''Malignant hyperthermia''' is "rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia."<ref>{{MeSH}}</ref> | ||
==Diagnosis== | |||
Patients at risk of malignant hyperthermia can be identified with the caffeine halothane contracture test (CHCT) using biopsied muscle. This test is very [[sensitivity (tests)|sensitive]] but not [[specificity (tests)|specific]]. | |||
Genetic testing can identify approximately one individuals at risk and is very [[specificity (tests)|specific]].<ref name="titleFAQs - Molecular Genetic Testing for MH">{{cite web |url=http://medical.mhaus.org/index.cfm/fuseaction/Content.Display/PagePK/MolecularGeneticsFAQ.cfm |title=FAQs - Molecular Genetic Testing for MH |accessdate=2008-04-02 |author=Anonymous |authorlink= |coauthors= |date= |format= |work= |publisher=Malignant Hyperthermia Association of the United States |pages= |language= |archiveurl= |archivedate= |quote=}}</ref> | |||
==See also== | |||
* [[Neuroleptic malignant syndrome]] | |||
* [[Serotonin syndrome]] | |||
==References== | ==References== | ||
{{reflist}}[[Category:Suggestion Bot Tag]] | |||
Latest revision as of 06:01, 15 September 2024
Malignant hyperthermia is "rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia."[1]
Diagnosis
Patients at risk of malignant hyperthermia can be identified with the caffeine halothane contracture test (CHCT) using biopsied muscle. This test is very sensitive but not specific.
Genetic testing can identify approximately one individuals at risk and is very specific.[2]
See also
References
- ↑ Anonymous (2024), Malignant hyperthermia (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Anonymous. FAQs - Molecular Genetic Testing for MH. Malignant Hyperthermia Association of the United States. Retrieved on 2008-04-02.